FDA reverses stance on autism drug

The US Food and Drug Administration is no longer recommending a high-dose B vitamin medication (leucovorin) as a potential treatment for autism. Last fall, Health and Human Services Secretary Robert Kennedy Jr. claimed the drug could be a therapy for thousands of children with the condition.